Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System

Brief Report: Validation Study of the IASLC Histological Grading System of Invasive Lung Adenocarcinoma1

(2021) Mariyo Rokutan-Kurata et al.   Journal of Thoracic Oncology

Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver Mutations

(2021) Chaoqiang Deng et al.   Journal of Thoracic Oncology

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

(2020) Andre L. Moreira et al.   Journal of Thoracic Oncology

Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma

(2015) Shuji Murakami et al.   LUNG CANCER

Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease

(2014) A. D. Campos-Parra et al.   EUROPEAN RESPIRATORY JOURNAL

Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non–Small-Cell Lung Cancer Receiving Radiotherapy: Meta-Analysis

(2014) Feifei Na et al.   Journal of Thoracic Oncology

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

(2013) Prudence A. Russell et al.   Journal of Thoracic Oncology

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations

(2013) Koji Tsuta et al.   LUNG CANCER

High Incidence of EGFR Mutations in Korean Men Smokers with No Intratumoral Heterogeneity of Lung Adenocarcinomas: Correlation with Histologic Subtypes, EGFR/TTF-1 Expressions, and Clinical Features

(2012) Ping-Li Sun et al.   Journal of Thoracic Oncology

Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients

(2012) Akihiko Yoshizawa et al.   Journal of Thoracic Oncology

Prognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non–Small Cell Lung Cancer

(2012) Helen H. W. Chen et al.   RADIOLOGY

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project

(2009) Thierry Berghmans et al.   Journal of Thoracic Oncology

Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

(2008) Noriko Motoi et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY